Erythema News and Research

RSS
FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Sequencing data could be used to prevent lyme disease

Sequencing data could be used to prevent lyme disease

Wear protective clothing to reduce the risk of skin damage from sun's UV rays

Wear protective clothing to reduce the risk of skin damage from sun's UV rays

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

Blocking activity of plasma protein can be possible way to protect against radiation-induced injury

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

FDA approves Cassipa sublingual film for maintenance treatment of opioid dependence

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

New point-of-care test accelerates diagnosis of Lyme neuroborreliosis

New point-of-care test accelerates diagnosis of Lyme neuroborreliosis

New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment

New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment

Study: Living Lyme disease bacteria found months after antibiotic treatment

Study: Living Lyme disease bacteria found months after antibiotic treatment

Researchers identify risk factor for drug-induced skin disease in diabetic patients

Researchers identify risk factor for drug-induced skin disease in diabetic patients

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

New biomarkers for early Lyme Disease identified

New biomarkers for early Lyme Disease identified

FDA approves first drug for treating rare form of Batten disease

FDA approves first drug for treating rare form of Batten disease